Ishida, Princess M.
HRN: 17-72-85 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2025
CEFUROXIME 750MG (VIAL)
07/30/2025
08/06/2025
IV
750mg
Q8
Abrasions
Checking Initial Appropriateness
07/30/2025
MUPIROCIN 2%, 15G (TUBE)
07/30/2025
08/06/2025
TOPICAL
Apply On Affected Area
Bid
Abrasions
Checking Initial Appropriateness